Targeting Breast Tumors with pH (Low) Insertion Peptides

por Adochite, Ramona-Cosmina, Moshnikova, Anna, Carlin, Sean D., Guerrieri, Renato A., Andreev, Oleg A., Lewis, Jason S., Reshetnyak, Yana K.
Publicado 2014

Reproducibility of (18)F-fluoromisonidazole intratumour distribution in non-small cell lung cancer

por Grkovski, Milan, Schwartz, Jazmin, Rimner, Andreas, Schöder, Heiko, Carlin, Sean D., Zanzonico, Pat B., Humm, John L., Nehmeh, Sadek A.
Publicado 2016

A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer

por Adumeau, Pierre, Carnazza, Kathryn E., Brand, Christian, Carlin, Sean D., Reiner, Thomas, Agnew, Brian J., Lewis, Jason S., Zeglis, Brian M.
Publicado 2016

Chemoenzymatic Strategy for the Synthesis of Site-Specifically Labeled Immunoconjugates for Multimodal PET and Optical Imaging

por Zeglis, Brian M., Davis, Charles B., Abdel-Atti, Dalya, Carlin, Sean D., Chen, Aimei, Aggeler, Robert, Agnew, Brian J., Lewis, Jason S.
Publicado 2014

Tumor-Specific Zr-89 Immuno-PET Imaging in a Human Bladder Cancer Model

por Escorcia, Freddy E., Steckler, Jeffrey M., Abdel-Atti, Dalya, Price, Eric W., Carlin, Sean D., Scholz, Wolfgang W., Lewis, Jason S., Houghton, Jacob L.
Publicado 2018

In vivo visualization of PARP inhibitor pharmacodynamics

por McDonald, Elizabeth S., Pantel, Austin R., Shah, Payal D., Farwell, Michael D., Clark, Amy S., Doot, Robert K., Pryma, Daniel A., Carlin, Sean D.
Publicado 2021

Noninvasive Imaging of PSMA in Prostate Tumors with (89)Zr-Labeled huJ591 Engineered Antibody Fragments: The Faster Alternatives

por Viola-Villegas, Nerissa Therese, Sevak, Kuntal K., Carlin, Sean D., Doran, Michael G., Evans, Henry W., Bartlett, Derek W., Wu, Anna M., Lewis, Jason S.
Publicado 2014

Imaging EGFR and HER3 through (89)Zr-labeled MEHD7945A (Duligotuzumab)

por McKnight, Brooke N., Kuda-Wedagedara, Akhila N. W., Sevak, Kuntal K., Abdel-Atti, Dalya, Wiesend, Wendy N., Ku, Anson, Selvakumar, Dakshnamurthy, Carlin, Sean D., Lewis, Jason S., Viola-Villegas, Nerissa T.
Publicado 2018

PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure–Activity Optimization Study

por Demoin, Dustin Wayne, Wyatt, Linden C., Edwards, Kimberly J., Abdel-Atti, Dalya, Sarparanta, Mirkka, Pourat, Jacob, Longo, Valerie A., Carlin, Sean D., Engelman, Donald M., Andreev, Oleg A., Reshetnyak, Yana K., Viola-Villegas, Nerissa, Lewis, Jason S.
Publicado 2016

Pilot study of PET imaging of (124)I-iodoazomycin galactopyranoside (IAZGP), a putative hypoxia imaging agent, in patients with colorectal cancer and head and neck cancer

por O’Donoghue, Joseph A, Guillem, José G, Schöder, Heiko, Lee, Nancy Y, Divgi, Chaitanya R, Ruby, Jeannine A, Humm, John L, Lee-Kong, Steven A, Burnazi, Eva M, Cai, Shangde, Carlin, Sean D, Leibold, Tobias, Zanzonico, Pat B, Ling, C Clifton
Publicado 2013

Pre-clinical investigation of astatine-211-parthanatine for high-risk neuroblastoma

por Makvandi, Mehran, Samanta, Minu, Martorano, Paul, Lee, Hwan, Gitto, Sarah B., Patel, Khushbu, Groff, David, Pogoriler, Jennifer, Martinez, Daniel, Riad, Aladdin, Dabagian, Hannah, Zaleski, Michael, Taghvaee, Tara, Xu, Kuiying, Lee, Ji Youn, Hou, Catherine, Farrel, Alvin, Batra, Vandana, Carlin, Sean D., Powell, Daniel J., Mach, Robert H., Pryma, Daniel A., Maris, John M.
Publicado 2022